Sponsors
Blog
Where our team of editors discuss what they think about the current NGP US Issues.
Editor NGP Europe
Tough competition
The battle between generics and branded products has been going on for a long time: the claims and counter claims over Aspirin, for example, have been in process since the early 20th century.06 Aug 2009
White Papers
Focus Area: Clinical Trials
R&D: The NGP Head-to-Head
Research and development is the oxygen of modern pharmaceuticals – and there is a problem with supply.
“New science for better decisions”
Julia Puppe talks with Jan Lundberg, Executive VP, Global Head of Discovery at AstraZeneca, about R&D efficiency, collaborations and building a major international presence in the research and development of biological therapeutics.
Failing faster
Failing faster and cheaper is becoming increasingly important to the pharmaceutical industry. But how? Rebecca Goozee reports.
What next for clinical research?
By Dr Douglas Peddicord, Executive Director of the Association of Clinical Research Organisations (ACRO)
Noninvasive Imaging in Drug Discovery and Development.
Noninvasive imaging techniques in drug discovery and development are process transforming tools that have the potential to fundamentally alter our approach to the challenges we face.
Source: www.ngpharma.eu.com© 2010 GDS Publishing Ltd. All rights reserved.